Cabot (CBT) is back on investor radar after its recent share performance, with the stock closing at US$80.88 and showing mixed returns over the past week, month, and past 3 months.

That recent pullback, including a 1 day share price return of down 2.6% and 7 day share price return of down 7.6%, comes after a stronger run. The 90 day share price return of 15.5% and 1 year total shareholder return of 10.4% may indicate changing confidence in Cabot’s earnings power and risk profile.

If Cabot’s move has you rethinking materials exposure, it could be a moment to widen your research and look at other specialty producers through our 8 top copper producer stocks

With Cabot trading near its analyst price target and showing a modest intrinsic discount, the key question now is whether the recent weakness signals an undervalued specialty materials stock or whether the market is already pricing in future growth.

Preferred P/E of 14.9x: Is it justified?

Cabot is trading on a P/E of 14.9x, which sits well below both the US Chemicals industry average of 27.8x and a peer average of 29.9x, even after the recent pullback to $80.88.

P/E compares the current share price to earnings per share. It gives a quick read on how much investors are paying for each dollar of current earnings. For a specialty chemicals and performance materials business with established products in tires, batteries and coatings, this lens helps you see how the market is weighing current profitability against expectations for future demand.

According to the statements, Cabot is viewed as good value on this metric compared with both its industry and its peer group, despite a recent period of earnings decline of 34% and softer net profit margins of 7.9% versus 10.9% last year. The current P/E may suggest the market is applying a discount to those earnings, even though Cabot reports high quality past earnings and has been profitable over the past 5 years, with earnings growing over that period.

The contrast is clear when you line up the numbers. Cabot’s 14.9x P/E is roughly half the 27.8x average for the broader US Chemicals industry and also sits well below the 29.9x peer average. This points to a meaningful valuation gap on this measure.

Result: Price-to-earnings of 14.9x (UNDERVALUED)

However, the narrative can quickly change if earnings softness persists or if demand in key end markets such as tires, batteries and coatings weakens further.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Another view on Cabot’s value

While the current 14.9x P/E paints Cabot as inexpensive next to the US Chemicals industry on 27.8x and peers on 29.9x, our DCF model also points to the stock trading at a 6.2% discount to an estimated fair value of $86.23. The question is whether that gap reflects caution on earnings quality or an opportunity if conditions stabilise.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Cabot for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 49 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Uncertain whether Cabot’s recent moves point to a bargain or a value trap? Act while the data is fresh, weigh both sides, and check the 2 key rewards and 1 important warning sign

Looking for more investment ideas?

If Cabot has sharpened your focus on opportunities, do not stop here. Broaden your watchlist now so you are not late to the next idea.

• Target income potential with companies offering higher yields and resilient payouts through the 9 dividend fortresses
• Hunt for quality at a discount by scanning companies that look mispriced on fundamentals using the 49 high quality undervalued stocks
• Zero in on companies with strong balance sheets and solid fundamentals via the solid balance sheet and fundamentals stocks screener (46 results)

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.